Pratik S. Multani
Net Worth

Last updated:

What is Pratik S. Multani net worth?

The estimated net worth of Dr. Pratik S. Multani is at least $2,437,976 as of 16 Dec 2024. He owns shares worth $445,670 as insider, has earned $125,436 from insider trading and has received compensation worth at least $1,866,870 in ORIC Pharmaceuticals, Inc..

What is the salary of Pratik S. Multani?

Dr. Pratik S. Multani salary is $622,290 per year as Chief Medical Officer in ORIC Pharmaceuticals, Inc..

How old is Pratik S. Multani?

Dr. Pratik S. Multani is 58 years old, born in 1967.

What stocks does Pratik S. Multani currently own?

As insider, Dr. Pratik S. Multani owns shares in one company:

Company Title Shares Price per share Total value
ORIC Pharmaceuticals, Inc. (ORIC) Chief Medical Officer 46,765 $9.53 $445,670

What does ORIC Pharmaceuticals, Inc. do?

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

ORIC logo
ORIC
ORIC Pharmaceuticals, Inc.
$9.53

Pratik S. Multani insider trading

ORIC Pharmaceuticals, Inc.

Dr. Pratik S. Multani has made 3 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he sold 8,850 units of ORIC stock worth $73,296 on 16 Dec 2024.

The largest trade he's ever made was exercising 24,042 units of ORIC stock on 15 Dec 2024. As of 16 Dec 2024 he still owns at least 46,765 units of ORIC stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 8,850 $8.28 $73,296
Option
Restricted Stock Unit 8,000 N/A N/A
Option
Restricted Stock Unit 10,000 N/A N/A
Option
Restricted Stock Unit 6,042 N/A N/A
Option
Common Stock 24,042 N/A N/A
Option
Restricted Stock Unit 8,000 N/A N/A
Sale
Common Stock 5,282 $8.59 $45,351
Option
Common Stock 14,042 N/A N/A
Option
Restricted Stock Unit 6,042 N/A N/A
Sale
Common Stock 2,089 $3.25 $6,789
Option
Common Stock 6,041 N/A N/A
Option
Restricted Stock Unit 6,041 N/A N/A

ORIC Pharmaceuticals key executives

ORIC Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Jacob M. Chacko M.B.A., M.D. (46) Pres, Chief Executive Officer & Director
  • Dr. Pratik S. Multani (58) Chief Medical Officer
  • Mr. Dominic G. Piscitelli CPA, M.B.A., CPA (50) Chief Financial Officer